Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Urologe A ; 51(2): 204-11, 2012 Feb.
Article in German | MEDLINE | ID: mdl-22269989

ABSTRACT

Together with comprehension and therapy of neurogenic failure of the storage function of the urinary bladder, intermittent catheterization as a pressure-free voiding method without residual urine, represents a major principle of therapy in lower urinary tract dysfunction. Aseptic intermittent catheterization is recommended in Germany and Europe and seems to be acceptable even in long-term application with low complication rates. It is a precondition that patients are seen for clinical and urodynamic reevaluation at risk-adapted time intervals. The major focus is on early recognition and avoidance of threatening complications. The most important preventive measures are the motivation and compliance of the well-educated patient and the use of careful catheterization techniques with individually optimized catheters.Although aseptic intermittent catheterization has been used effectively for many years there is still a lack of randomized controlled studies for some important questions of details and an optimal catheter has still to be defined. Furthermore, valid conclusions based on well-conducted studies on the self-estimated quality of life of patients with intermittent catheterization, especially those with catheterization by attendant, are urgently needed. Intermittent catheterization is never a ready-made solution but always an individually tailored treatment for patients with lower urinary tract dysfunction.


Subject(s)
Lower Urinary Tract Symptoms/therapy , Urinary Bladder, Neurogenic/therapy , Urinary Catheterization , Urodynamics/physiology , Guideline Adherence , Humans , Long-Term Care , Lower Urinary Tract Symptoms/physiopathology , Lower Urinary Tract Symptoms/psychology , Motivation , Patient Compliance , Quality of Life/psychology , Spinal Cord Injuries/complications , Spinal Cord Injuries/physiopathology , Urinary Bladder, Neurogenic/physiopathology , Urinary Bladder, Neurogenic/psychology , Urinary Catheterization/methods , Urinary Catheterization/psychology
2.
Urologe A ; 46(3): 293-6, 2007 Mar.
Article in German | MEDLINE | ID: mdl-17295036

ABSTRACT

Due to elevated intravesical storage pressures, neurogenic bladder dysfunction carries a high risk of renal damage. Thus, the goals of neurourologic treatment are reduction of intravesical storage pressure and intermittent bladder emptying in order to protect renal function and to achieve continence. If anticholinergic medication is either ineffective or intolerable, several open and controlled studies showed that the injection of botulinum toxin A into the detrusor muscle is a minimally invasive, safe, and effective treatment option. These studies demonstrated an effective reduction of storage pressures and a significant increase in bladder capacity. The effect has been shown to last up to a year. As this treatment is not approved by European administrations, botulinum toxin A treatment fulfills all criteria for "justified off-label use." The reduction of intravesical storage pressure leads to an improvement of life expectancy due to upper urinary tract protection. Furthermore, quality of life can be improved by low incidence of urinary tract infections, secure continence, and physiologic catheterization intervals.


Subject(s)
Botulinum Toxins, Type A/therapeutic use , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Urinary Bladder, Neurogenic/drug therapy , Urinary Bladder, Neurogenic/prevention & control , Germany , Humans
3.
Aktuelle Urol ; 37(2): 138-40, 2006 Mar.
Article in German | MEDLINE | ID: mdl-16625471

ABSTRACT

BACKGROUND: Secondary tumors of the testes are rare. In about 15 % of the cases they are metastases of a malignant melanoma, there are about 30 reports of such cases in the literature. Most of them describe findings at post-mortem, in only 4 of the previously described cases testicular metastases were the first manifestation of a melanoma. The transformation of a benign, meningeal melanocytoma into a malignant melanoma has only been described once world-wide. The problems in the diagnosis and therapy of this extremely rare tumor are discussed on the basis of a further patient with metastases of the testes as primary manifestation of a malignant melanoma. CASE REPORT: We report on a 74-year-old man who presented with a relatively rapidly developing but less painful swelling of the left testicle. The case history disclosed operations 10 and 3.5 year earlier for an apparently benign melanocytoma at the level of the 11th and 12th thoracic vertebrae, a local recurrence with paraparesis was known at the time of admission. Sonography revealed an inhomogeneous tumor effecting the entire left testicle. Therapy comprised an inguinal, radical orchiectomy. The correct diagnosis was made histologically. Shortly after the operation, a diffuse, subcutaneous and hepatic metastases occurred. CONCLUSION: In the case of a primary manifestation a correct preoperative diagnosis is unusual. Radical orchiectomy is the treatment of choice for a suspected primary testicular tumor. The prognosis is accordingly poor. In elderly patients with unclear testicular tumors metastases from an (occult) tumor disease must be taken into consideration.


Subject(s)
Cell Transformation, Neoplastic/pathology , Melanocytes , Melanoma/secondary , Meningeal Neoplasms/diagnosis , Precancerous Conditions/diagnosis , Testicular Neoplasms/secondary , Aged , Diagnosis, Differential , Disease Progression , Humans , Magnetic Resonance Imaging , Male , Melanocytes/pathology , Melanoma/diagnosis , Melanoma/pathology , Melanoma/surgery , Meningeal Neoplasms/pathology , Meningeal Neoplasms/surgery , Neoplasm Invasiveness/pathology , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/surgery , Orchiectomy , Precancerous Conditions/pathology , Precancerous Conditions/surgery , Testicular Neoplasms/diagnosis , Testicular Neoplasms/pathology , Testicular Neoplasms/surgery , Testis/pathology , Ultrasonography
4.
Urologe A ; 43(1): 52-63, 2004 Jan.
Article in German | MEDLINE | ID: mdl-14747928

ABSTRACT

Spinal cord injury is known to have a major impact on human sexual function. The disturbances depend on the level and completeness of the lesion. The majority of people affected by spinal cord injury are young and in their reproductive years. In these cases sexuality reflects an important aspect of personality, and therefore special attention needs to be given to this issue during rehabilitation. Sexual rehabilitation encompasses both comprehensive information and consultation as well as diagnosis and treatment of disturbed sexual functions. Successful rehabilitation and integration depend also on restoration of sexual function or adequate therapy of sexual dysfunction. This review will consider the present knowledge about the impact of spinal cord injury on female and male sexual function, the currently available treatment options as well as the aspects of fertility and reproduction in this patient population.


Subject(s)
Reproductive Behavior/psychology , Sexual Dysfunction, Physiological/etiology , Sexual Dysfunction, Physiological/rehabilitation , Sexual Dysfunctions, Psychological/etiology , Sexual Dysfunctions, Psychological/rehabilitation , Sexuality/psychology , Spinal Cord Injuries/complications , Spinal Cord Injuries/rehabilitation , Female , Humans , Male , Sexual Dysfunction, Physiological/psychology , Sexual Dysfunctions, Psychological/psychology , Spinal Cord Injuries/psychology
5.
Br J Urol ; 75(4): 452-6, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7788255

ABSTRACT

OBJECTIVE: To compare trospium chloride (TCl), a quaternary ammonium derivative with atropine-like effects and predominantly antispasmodic activity, with oxybutynin (Oxy) in terms of efficacy and adverse effects. PATIENTS AND METHODS: In a randomized, double-blind, multicentre trial, 95 patients with spinal cord injuries and detrusor hyper-reflexia were studied. Treatment consisted of three doses per day over a 2 week period, with either Oxy (5 mg three times daily) or with TCl (20 mg twice daily) with an additional placebo at midday. The results were evaluated with regard to changes in objective (urodynamic) data and subjective symptoms as well as the incidence/severity of adverse effects. RESULTS: With both drugs there was a significant increase in maximum bladder capacity, a significant decrease in maximum voiding detrusor pressure and a significant increase in compliance and residual urine; there were no statistically significant differences between the treatment groups. The percentage of patients who reported severe dryness of the mouth was considerably lower (4%) in those receiving TCl 2 x 20 mg/day than in those receiving Oxy (23%) 3 x 5 mg/day. Withdrawal from treatment was also less frequent in those receiving TCl (6%) than in those receiving Oxy (16%). CONCLUSION: Trospium chloride and oxybutynin, judged in terms of objective urodynamic parameters, are of substantially equal value as parasympathetic antagonists. However, assessment of tolerance in terms of adverse drug effects showed that TCl had certain advantages.


Subject(s)
Mandelic Acids/therapeutic use , Nortropanes/therapeutic use , Parasympatholytics/therapeutic use , Reflex, Abnormal/drug effects , Urinary Bladder/drug effects , Adolescent , Adult , Benzilates , Double-Blind Method , Female , Humans , Male , Middle Aged , Nortropanes/adverse effects , Parasympatholytics/adverse effects , Pressure , Treatment Outcome , Urination/drug effects , Urodynamics
6.
Paraplegia ; 31(2): 102-4, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8446452

ABSTRACT

In recent years those working in German SCI centres have realised that a growing number of young adults with myelodysplasia are seeking special treatment because of the lack of comprehensive and lifelong care. Statistical investigations, collected over a period of nine years, demonstrate that only severe complications in soft tissues, urology and equipment have led to an admission. The capacity of the centres is limited, and more facilities are necessary. There is a political demand.


Subject(s)
Neural Tube Defects/therapy , Adolescent , Adult , Child , Child, Preschool , Female , Germany , Humans , Infant , Male , Neural Tube Defects/complications , Paralysis/complications , Paralysis/therapy , Pressure Ulcer/therapy , Urodynamics
7.
Urol Int ; 47(3): 138-43, 1991.
Article in English | MEDLINE | ID: mdl-1771701

ABSTRACT

In a multicentre placebo-controlled double-blind study 61 patients with spinal cord injuries and detrusor hyperreflexia were treated: 20 mg trospium chloride was given twice daily over a period of 3 weeks. Pre- and posttreatment urodynamic measurements demonstrated large improvements in maximum cystometric capacity (mean = 138.1 ml), decreased maximum detrusor pressure (mean = -37.8 cm H2O) and an increase in compliance (mean = 12.1 ml/cm H2O) in the treatment group. Urodynamic parameters in the placebo group remained substantially unchanged. Comparisons between the two groups revealed highly significant differences for these parameters (all, p less than 0.001). No effect on maximum flow rate and residual urine was detected in either group. The incidence of spontaneously reported side-effects was extremely low and comparable for both groups.


Subject(s)
Nortropanes/therapeutic use , Parasympatholytics/therapeutic use , Spinal Cord Injuries/complications , Urinary Bladder, Neurogenic/drug therapy , Adult , Benzilates , Double-Blind Method , Female , Humans , Male , Nortropanes/adverse effects , Parasympatholytics/adverse effects , Pressure , Urinary Bladder/physiopathology , Urinary Bladder, Neurogenic/etiology , Urinary Bladder, Neurogenic/physiopathology , Urodynamics
8.
Zentralbl Hyg Umweltmed ; 189(2): 175-84, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2513821

ABSTRACT

84 Pseudomonas aeruginosa strains from 29 paraplegic patients with urinary tract infections (UTI) and from the water reservoirs of specialized wards in two German hospitals were typed using a P. aeruginosa-specific DNA probe. P. aeruginosa strains were present in 51% of all accessible water reservoirs, including sinks of wash-basins and toilets in the wards. 14 of the 29 patients with UTI (48%) were infected by P. aeruginosa strains which were also isolated from these sources. Groups of up to four patients were infected by single strains. Some of the strains persisted in the wards and were isolated from the water reservoirs five to eight months after causing UTI. 89.5% of the investigated water samples yielded P. aeruginosa strains which were identical with strains from up to nine other sites. The wide distribution of single P. aeruginosa genotypes in the ward, the isolation of strains causing UTI from rooms inaccessible to the patients, and the outbreak of UTI caused by single, identical P. aeruginosa strains in groups of patients within short time periods, suggest that the strains are distributed by the personnel rather than by the patients who for the most part are immobile.


Subject(s)
Cross Infection/etiology , Disease Outbreaks , Paraplegia/complications , Pseudomonas Infections/etiology , Urinary Tract Infections/etiology , Cross Infection/epidemiology , Cross Infection/microbiology , Genotype , Humans , Pseudomonas Infections/epidemiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/classification , Pseudomonas aeruginosa/genetics , Urinary Tract Infections/epidemiology , Urinary Tract Infections/microbiology , Water Microbiology
9.
Rontgenblatter ; 39(6): 143-5, 1986 Jun.
Article in German | MEDLINE | ID: mdl-3523725

ABSTRACT

The authors present the case of a 61-year old man with microhematuria, in whom the preoperative diagnostic work-up (urography, percutaneous sonography, CT, retrograde pyelogram) had led to the diagnosis of a right sided renal tumour. Intraoperatively a kidney tumour was neither seen nor palpated. However, the mass was clearly outlined by intraoperative sonography. The following nephrectomy revealed an intrarenal adenocarcinoma of the kidney of 2.5 cm diameter.


Subject(s)
Adenocarcinoma/diagnosis , Intraoperative Care , Kidney Neoplasms/diagnosis , Ultrasonography , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Humans , Kidney/diagnostic imaging , Kidney/pathology , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Male , Middle Aged , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...